Your browser doesn't support javascript.
loading
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity.
Maurer, Mark F; Lewis, Katherine E; Kuijper, Joseph L; Ardourel, Dan; Gudgeon, Chelsea J; Chandrasekaran, Siddarth; Mudri, Sherri L; Kleist, Kayla N; Navas, Chris; Wolfson, Martin F; Rixon, Mark W; Swanson, Ryan; Dillon, Stacey R; Levin, Steven D; Kimbung, Yengo Raymond; Akutsu, Masato; Logan, Derek T; Walse, Björn; Swiderek, Kristine M; Peng, Stanford L.
Afiliação
  • Maurer MF; Alpine Immune Sciences, Inc., Seattle, WA, USA. Mark.Maurer@AlpineImmuneSciences.com.
  • Lewis KE; Alpine Immune Sciences, Inc., Seattle, WA, USA.
  • Kuijper JL; Alpine Immune Sciences, Inc., Seattle, WA, USA.
  • Ardourel D; Alpine Immune Sciences, Inc., Seattle, WA, USA.
  • Gudgeon CJ; Alpine Immune Sciences, Inc., Seattle, WA, USA.
  • Chandrasekaran S; Alpine Immune Sciences, Inc., Seattle, WA, USA.
  • Mudri SL; Notch Therapeutics, Inc., Seattle, WA, USA.
  • Kleist KN; Alpine Immune Sciences, Inc., Seattle, WA, USA.
  • Navas C; Alpine Immune Sciences, Inc., Seattle, WA, USA.
  • Wolfson MF; Alpine Immune Sciences, Inc., Seattle, WA, USA.
  • Rixon MW; Lyell Immunopharma, Inc., Seattle, WA, USA.
  • Swanson R; Alpine Immune Sciences, Inc., Seattle, WA, USA.
  • Dillon SR; Alpine Immune Sciences, Inc., Seattle, WA, USA.
  • Levin SD; Alpine Immune Sciences, Inc., Seattle, WA, USA.
  • Kimbung YR; Neoleukin Therapeutics, Inc., Seattle, WA, USA.
  • Akutsu M; Alpine Immune Sciences, Inc., Seattle, WA, USA.
  • Logan DT; Alpine Immune Sciences, Inc., Seattle, WA, USA.
  • Walse B; Parvus Therapeutics, Inc., South San Francisco, CA, USA.
  • Swiderek KM; SARomics Biostructures AB, Medicon Villiage, Lund, Sweden.
  • Peng SL; SARomics Biostructures AB, Medicon Villiage, Lund, Sweden.
Nat Commun ; 13(1): 1790, 2022 04 04.
Article em En | MEDLINE | ID: mdl-35379805
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos CD28 / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos CD28 / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article